European Archives - Page 442 of 1109 - European Medical Journal

The impact of global instability

From R&D operations to manufacturing efforts, this infographic examines how the pharma sector is being affected by current global instability due to political turmoil and soaring energy prices.

The biotech rise, fall and rebound

This infographic reflects on the evolution of the biotech sector since 2016, tracking rising revenues, investment cuts and drugs that are making it to market.

Autumn 2022 Highlights

In this episode, Evgenia Koutsouki, editor of the EMJ family of journals, recalls the most noteworthy moments of the last 3 months on the EMJ podcasts.

Infographic: ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer

ESMO Recommendations for Diagnosis and Staging of Metastatic Non-Small-Cell Lung Cancer. Bronchoscopy: for central lesions; can be paired with bronchial washing, brushing, and bronchial and transbronchial biopsy

Top tips for digital innovation and the future of patient centricity

Helena is joined by well-known pharma conference speaker Konrad Dobschuetz to discuss his top tips for digital innovation in the pharma industry.

Moderna joins BIA as 500th member

Moderna has joined the UK’s BioIndustry Association (BIA), taking the trade association’s membership to over 500 companies.

Interview: Naveed Sattar

EMJ spoke with Naveed Sattar, Professor of Metabolic Medicine, University of Glasgow, about developments in diabetes and awareness of metabolic disease…

Roundtable: a discussion on the pandemic and gender parity

Hear from two industry thought leaders to find out how the pharmaceutical industry is harnessing the COVID-19 to advance rather than derail their mission to improve female representation.

A roundtable on clinical trial transformation

Clinical trials of the past struggled with patient enrolment and cost efficiency. What can the pharmaceutical industry learn to improve them?

Roundtable: the evolving landscape of patient advocacy

In this roundtable, hear from two industry thought leaders who share their ideas on how to build synergy between pharma and patients.